We will create mice and rats with drug metabolism similar to that of humans!
We have created human-like drug metabolism model mice and rats equipped with artificial chromosome vectors carrying human drug metabolism-related genes. By administering new drugs, we can predict safety for humans, leading to accelerated pharmaceutical development and reduced costs. 【Features】 ■ Improved prediction of safety for humans ■ Accelerated pharmaceutical development and increased success rates ■ Lower costs for new drug development and reduced national healthcare burden *For more details, please refer to the catalog or feel free to contact us.
Inquire About This Product
basic information
【Business Concept】 ■ Development of rat models for human antibody production ■ Verification experiments of antibody drugs using large animals ■ Application to genetically rare diseases (development of model animals, cell transplantation therapy) ■ Medium to long-term next-generation business plan *For more details, please refer to the catalog or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the catalog or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
TransChromosomics Co., Ltd. is a Tottori University-based biotech venture established with the aim of developing drug discovery and drug discovery support tools, leveraging the know-how of chromosome engineering technology acquired by CEO Mitsuo Oshimura during his 30 years of research. Using cutting-edge chromosome engineering technology, the company conducts chromosome modification, iPS/ES cell production, genetically modified mouse and rat production, animal testing, and antibody production, among other activities.